Patents by Inventor Lane Desborough

Lane Desborough has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230173176
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to one or more back-filled time segments associated with a diurnal time block.
    Type: Application
    Filed: January 31, 2023
    Publication date: June 8, 2023
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Publication number: 20230098036
    Abstract: Methods of insulin delivery may include Selecting a basal insulin delivery rate responsive to a projected blood glucose level that approximates a target blood glucose level. Methods of insulin delivery may further include generating insulin delivery instructions for an insulin delivery device, the insulin delivery instructions corresponding to the basal insulin delivery rate and for a variable time duration relative to an intended time duration.
    Type: Application
    Filed: November 29, 2022
    Publication date: March 30, 2023
    Inventors: Bryan Mazlish, Lane Desborough
  • Publication number: 20230064614
    Abstract: One or more embodiments of the disclosure relate, generally, to a diabetes management system. Such a diabetes management system may include a flash glucose monitor and a user interface. The user interface may be configured to display one or more of graphical representations of glucose values and value representative of glucose measurements, and to change values displayed responsive to user interaction with the user interface.
    Type: Application
    Filed: October 10, 2022
    Publication date: March 2, 2023
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11565045
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to one or more back-filled time segments associated with a diurnal time block.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: January 31, 2023
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Publication number: 20230009339
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Some methods and systems may be configured to adjust insulin delivery to a person with diabetes according to one or more conditions of an insulin delivery device. Some methods and systems may be configured to enable a lock-out mode where adjustment to insulin delivery to personalize automated insulin delivery is restricted.
    Type: Application
    Filed: September 19, 2022
    Publication date: January 12, 2023
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Patent number: 11547805
    Abstract: One or more embodiments of the disclosure are related, generally, to a reusable accessory for a manual medication delivery device. Such a reusable accessory may include a wireless communication interface, a detection circuitry, and a recommendation system. In one or more embodiments, an adapter may be configured to reversibly couple such a reusable accessory to a manual medication delivery device. Dosing events may be detected that are associated with dosing at the manual medication delivery device. Dose recommendations may be provided responsive to analyte measurements and/or dosing events.
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: January 10, 2023
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11511039
    Abstract: Methods of insulin delivery may include obtaining one or more blood glucose readings from a flash glucose monitor, where the blood glucose readings may be obtained in response to a user invocation of the flash glucose monitor. The method may also include generating multiple insulin delivery profiles of insulin delivery actions over multiple diurnal time segments based on the one or more blood glucose readings. The method may additionally include selecting one of the delivery profiles that is projected to approximate a target blood glucose level, and delivering insulin according to the selected delivery profile. Systems may provide such insulin delivery.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: November 29, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough
  • Publication number: 20220339364
    Abstract: Diabetes management systems may include a glucose monitoring device adapted to transmit glucose data and at least one accessory in communication with the glucose monitoring device and adapted to provide at least one alarm or alert based on the glucose data.
    Type: Application
    Filed: July 11, 2022
    Publication date: October 27, 2022
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Patent number: 11464459
    Abstract: One or more embodiments of the disclosure relate, generally, to a diabetes management system. Such a diabetes management system may include a flash glucose monitor and a user interface. The user interface may be configured to display one or more of graphical representations of glucose values and value representative of glucose measurements, and to change values displayed responsive to user interaction with the user interface.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: October 11, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20220305212
    Abstract: One or more embodiments of the present disclosure may include an insulin delivery system that includes an insulin delivery device, a user interface that includes multiple user-selectable icons or buttons each representing different meal characteristics, memory to store one or more user-specific dosage parameter, and a processor in communication with the memory and adapted to receive blood glucose data. The processor may also be adapted to determine initial meal characteristics associated with each of the user-selectable icons or buttons based on at least one of the user-specific dosage parameters. The processor may also be adapted to update the meal characteristics associated with each of the user-selectable icons or buttons based upon the blood glucose data.
    Type: Application
    Filed: June 14, 2022
    Publication date: September 29, 2022
    Inventors: Per John Sjolund, Lane Desborough, Bryan Mazlish, Andrew Bochenko, Ross Naylor
  • Publication number: 20220305195
    Abstract: One or more embodiments relate, generally, to a reusable accessory for a medication injection pen. Such a reusable accessory may be adapted to be reversibly attached to a medication injection pen, and configured to detect an event associated with an injection of medication from the medication injection pen. It may also be configured to determine a percentage of medication that remains active for injection by the medication injection pen based on timing information and dosing event information.
    Type: Application
    Filed: June 14, 2022
    Publication date: September 29, 2022
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20220305208
    Abstract: One or more embodiments of the disclosure are related, generally, to a reusable accessory for a manual medication delivery device. Such a reusable accessory may include a wireless communication interface, a detection circuitry, and a recommendation system. In one or more embodiments, an adapter may be configured to reversibly couple such a reusable accessory to a manual medication delivery device. Dosing events may be detected that are associated with dosing at the manual medication delivery device. Dose recommendations may be provided responsive to analyte measurements and/or dosing events.
    Type: Application
    Filed: June 14, 2022
    Publication date: September 29, 2022
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20220305207
    Abstract: A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.
    Type: Application
    Filed: June 14, 2022
    Publication date: September 29, 2022
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Patent number: 11446439
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Some methods and systems may be configured to adjust insulin delivery to a person with diabetes according to one or more conditions of an insulin delivery device. Some methods and systems may be configured to enable a lock-out mode where adjustment to insulin delivery to personalize automated insulin delivery is restricted.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: September 20, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Publication number: 20220262478
    Abstract: Some embodiments include burden-free insulin delivery systems and methods. Some embodiments include a method comprising: receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining that the estimated glucose value is approaching or has passed a threshold; and in response to determining that the estimated glucose value is approaching or has surpassed the threshold, not providing an indication to the user through a user interface that the estimated glucose value is approaching or surpassed the threshold.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 18, 2022
    Inventor: Lane Desborough
  • Publication number: 20220262479
    Abstract: Some embodiments include burden-free insulin delivery systems and methods. In some embodiments, a method may include receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data to bring the estimated glucose data closer to a target glucose value without using any user-specific behavioral data physically entered by a user through a user interface of the user device within a previous period of time, the previous period of time being less than six hours; and communicating the insulin delivery amount to the insulin pump.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 18, 2022
    Inventor: Lane Desborough
  • Patent number: 11389088
    Abstract: A method of displaying blood glucose information may include monitoring blood glucose levels of a user, where the blood glucose levels include at least a current blood glucose level and a historic blood glucose level. The method may also include presenting the current blood glucose level using a point indicator along an approximately horizontally centered axis based on a non-linear scale, and presenting the historic blood glucose level and a predicted future blood glucose level on the display as a single smoothed curve passing the point indicator.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: July 19, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Lane Desborough, Bryan Mazlish, Sabine Kabel-Eckes, Jeff Boissier
  • Patent number: 11383043
    Abstract: Diabetes management systems may include a glucose monitoring device adapted to transmit glucose data and at least one accessory in communication with the glucose monitoring device and adapted to provide at least one alarm or alert based on the glucose data.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: July 12, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Publication number: 20220134017
    Abstract: A method may include displaying at least three icons on a user interface of a mobile device, including a first icon associated with the at least three icons associated with a first carbohydrate level, a second icon associated with the at least three icons associated with a second carbohydrate level, and a third icon associated with the at least three icons associated with a third carbohydrate level. The method may also include receiving a user selection of one of the three icons through the user interface of the mobile device, and determining an insulin bolus level from the user selection. The method may also include communicating the insulin bolus level to an insulin delivery device.
    Type: Application
    Filed: January 11, 2022
    Publication date: May 5, 2022
    Inventors: Lane Desborough, Bryan Mazlish, Andrew Bochenko, Ross Naylor, Jeff Boissier, Sabine Kabel-Eckes
  • Publication number: 20220105277
    Abstract: One or more embodiments of the disclosure relate, generally, to a replacement pen cap for a medication injection pen comprising at least one temperature sensor for monitoring a temperature of a medication, detect dosing events, and determine that medication may be denatured based on temperature data, received analyte measurement data prior, and the detected dosing events.
    Type: Application
    Filed: December 13, 2021
    Publication date: April 7, 2022
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough